Search Results

If the U.S. can help Japan reform its drug pricing controls, both countries stand to benefit.

Imagine a day alongside leaders advancing cell and gene therapies. The Advanced Therapies Xchange San Francisco 2026 brings together senior scientists to explore vector engineering, delivery, and manufacturing challenges. Through roundtables, presentations, and 1:1 meetings, gain practical insights and valuable connections. Registration is complimentary for qualified attendees.

Step into a day with leaders advancing AI in drug discovery. The AI in Drug Discovery Xchange San Francisco 2026 brings together senior industry leaders to explore data quality, target identification, and AI-driven design. Through roundtables, presentations, and 1:1 meetings, gain practical insights and valuable connections. Registration is complimentary for qualified attendees.

Spend a day with leaders advancing CNS therapeutics at the CNS Therapeutics Xchange San Francisco 2026. Senior leaders will explore challenges in target discovery, biomarkers, and CNS delivery. Through roundtables, presentations, and 1:1 meetings, gain practical insights and valuable connections. Registration is complimentary for qualified attendees.

Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stage Strengthened balance sheet by extinguishing $32 million in debt Subsequent to year-end, closed on transformational capital raise led by established institutional healthcare investors and completed enrollment of Pivotal Clinical Trial for first-of-its-kind fully implanted cochlear implant

Prestigious Late-Breaking Research Session Positions PH-762 as a Promising New PD-1 Directed Immunotherapy Candidate on March 28, 2026 at 3 PM (MDT)

• Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical Trials • Consistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue Systems